Published in Acta Obstet Gynecol Scand on February 01, 1995
Pelvic radiotherapy and sexual function in women. Transl Androl Urol (2015) 0.76
Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 10.03
Polychemotherapy in advanced non small cell lung cancer: a meta-analysis. Lancet (1993) 6.08
Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol (1998) 5.15
The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer (1994) 3.45
The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 3.40
The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 3.37
Short form 36 (SF-36) health survey: normative data from the general Norwegian population. Scand J Soc Med (1998) 2.53
Quality of life in palliative cancer care: results from a cluster randomized trial. J Clin Oncol (2001) 2.46
A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer (2000) 2.34
Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol (1999) 2.25
Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 2.22
Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res (1998) 2.22
Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol (1995) 2.08
Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 2.05
Cancer patients use of nonproven therapy: a 5-year follow-up study. J Clin Oncol (1998) 2.05
Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity. J Clin Epidemiol (1998) 1.93
Testing the equivalence of translations of widely used response choice labels: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.86
Clinical pharmacology of methadone for pain. Acta Anaesthesiol Scand (2008) 1.85
Population-based study of dying in hospital in six European countries. Palliat Med (2008) 1.84
A palliative-care intervention and death at home: a cluster randomised trial. Lancet (2000) 1.84
Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.79
The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiol Scand (2004) 1.77
Challenges in palliative care research; recruitment, attrition and compliance: experience from a randomized controlled trial. Palliat Med (1999) 1.64
Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine. Eur J Clin Pharmacol (2000) 1.63
Does use of alternative medicine predict survival from cancer? Eur J Cancer (2003) 1.62
A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data. Laryngoscope (2001) 1.61
Using reference data on quality of life--the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3). Eur J Cancer (1998) 1.60
Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+ 3). J Clin Oncol (1998) 1.59
Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures. J Clin Epidemiol (1998) 1.55
The length of consent documents in oncological trials is doubled in twenty years. Ann Oncol (2008) 1.54
A prospective study of quality of life in head and neck cancer patients. Part I: at diagnosis. Laryngoscope (2001) 1.50
Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients. Acta Oncol (1992) 1.45
Evaluation of modified crystal violet chromoendoscopy procedure using new mucosal pit pattern classification for detection of Barrett's dysplastic lesions. Dig Liver Dis (2006) 1.41
[Information and support to cancer patients. Experience from a course for young cancer patients at the Montebello Center]. Tidsskr Nor Laegeforen (1992) 1.39
How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial. Eur J Cancer (2011) 1.39
A prospective randomized comparative study on the safety and tolerability of transnasal esophagogastroduodenoscopy. Endoscopy (2005) 1.34
Fluid endocytosis in isolated rat parenchymal and non-parenchymal liver cells. Exp Cell Res (1980) 1.33
Psychological distress in head and neck cancer patients 7-11 years after curative treatment. Br J Cancer (1995) 1.29
Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys (1994) 1.28
Cluster-randomized trials. Palliat Med (2002) 1.28
Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients. Pain (2011) 1.28
Genetic variability and clinical efficacy of morphine. Acta Anaesthesiol Scand (2005) 1.27
Assessing the consistency of psychometric properties of the HRQoL scales within the EORTC QLQ-C30 across populations by means of the Mokken Scaling Model. Qual Life Res (1999) 1.20
Quality of life in advanced cancer patients: the impact of sociodemographic and medical characteristics. Br J Cancer (2001) 1.15
A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation. Bone Marrow Transplant (2004) 1.14
Physical exercise results in the improved subjective well-being of a few or is effective rehabilitation for all cancer patients? Eur J Cancer (2004) 1.13
Lack of concealment may lead to selection bias in cluster randomized trials of palliative care. Palliat Med (2002) 1.11
Measurement of health-related quality of life in multiple myeloma. Nordic Myeloma Study Group. Br J Haematol (1996) 1.09
Psychological distress after cancer cure: a survey of 459 Hodgkin's disease survivors. Br J Cancer (1997) 1.08
Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients. Pharmacogenomics J (2003) 1.06
A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients. Br J Cancer (1999) 1.06
Pain assessment tools in palliative care: an urgent need for consensus. Palliat Med (2008) 1.01
Chronic non-malignant pain patients report as poor health-related quality of life as palliative cancer patients. Acta Anaesthesiol Scand (2007) 1.01
Effect of physical exercise on muscle mass and strength in cancer patients during treatment--a systematic review. Crit Rev Oncol Hematol (2013) 1.00
Hodgkin's disease survivors more fatigued than the general population. J Clin Oncol (1999) 1.00
Malnutrition and food intake in relation to quality of life in head and neck cancer patients. Head Neck (1998) 0.98
Prognostic factors and survival in a heterogeneous sample of cancer patients. Br J Cancer (1996) 0.98
Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Br J Haematol (1999) 0.96
High level of fatigue in lymphoma patients treated with high dose therapy. J Pain Symptom Manage (2000) 0.96
Crystal structure of 1-aminocyclopropane-1-carboxylate deaminase from Hansenula saturnus. J Biol Chem (2000) 0.96
A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting: a randomized, double-blind study. International Emesis Study Group. Eur J Cancer (1990) 0.96
The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantation. Bone Marrow Transplant (1999) 0.96
Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients. Acta Anaesthesiol Scand (2003) 0.96
Classification of pain in cancer patients--a systematic literature review. Palliat Med (2009) 0.95
Reduced health-related quality of life among Hodgkin's disease survivors: a comparative study with general population norms. Ann Oncol (1999) 0.95
Quality of life in adult cancer patients treated with bone marrow transplantation--a review of the literature. Eur J Cancer (1995) 0.95
Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway. Eur J Cancer (1997) 0.94
Effects on cancer patients' health-related quality of life after the start of morphine therapy. J Pain Symptom Manage (2000) 0.94
Attitudes toward informing the cancer patient--a survey of Norwegian physicians. Eur J Cancer (1996) 0.93
Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: a Nordic Lymphoma Group Trial. Med Oncol (2001) 0.92
Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study. J Clin Oncol (1999) 0.91
Factors affecting grief reactions in close family members to individuals who have died of cancer. J Pain Symptom Manage (2001) 0.91
Long-term somatic side-effects and morbidity in testicular cancer patients. Br J Cancer (1990) 0.90
Fatigue and psychiatric morbidity among Hodgkin's disease survivors. J Pain Symptom Manage (2000) 0.90
Late medical complications and fatigue in Hodgkin's disease survivors. J Clin Oncol (2001) 0.89
Variable response to opioid treatment: any genetic predictors within sight? Palliat Med (2008) 0.88
Health-related quality of life and occurrence of intestinal side effects after pelvic radiotherapy--evaluation of long-term effects of diagnosis and treatment. Acta Oncol (2000) 0.88
Health status of people with epilepsy compared with a general reference population. Epilepsia (2000) 0.88
Exercise reduces fatigue in chronic fatigued Hodgkins disease survivors--results from a pilot study. Eur J Cancer (2003) 0.88
Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year? Bone Marrow Transplant (1999) 0.88
Patient self-reported and clinician-rated quality of life in head and neck cancer patients: a cross-sectional study. Eur J Cancer B Oral Oncol (1995) 0.87
Prospective, longitudinal quality-of-life study of patients with head and neck cancer: a feasibility study including the EORTC QLQ-C30. Otolaryngol Head Neck Surg (1997) 0.87
The first year of grief and bereavement in close family members to individuals who have died of cancer. Palliat Med (2001) 0.86
Uptake and degradation of 125I-labelled high density lipoproteins in rat liver cells in vivo and in vitro. Biochim Biophys Acta (1979) 0.86
CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial. Ann Oncol (1999) 0.86
Follow-up study of exchange transfusion for hyperbilirubinemia in infants in Japan. Pediatrics (1967) 0.85
Effect of interferon on the health-related quality of life of multiple myeloma patients: results of a Nordic randomized trial comparing melphalan-prednisone to melphalan-prednisone + alpha-interferon. The Nordic Myeloma Study Group. Br J Haematol (1996) 0.85
Long-term treatment with ketamine in a 12-year-old girl with severe neuropathic pain caused by a cervical spinal tumor. J Pediatr Hematol Oncol (2001) 0.84
The use of non-proven therapy among patients treated in Norwegian oncological departments. A cross-sectional national multicentre study. Eur J Cancer (1995) 0.84
Spiritual healing among Norwegian hospitalised cancer patients and patients' religious needs and preferences of pastoral services. Eur J Cancer (1996) 0.83
Pain in patients living in Norwegian nursing homes. Palliat Med (2008) 0.83
Intracellular degradation of 125I-labelled asialo-glycoproteins in rat hepatocytes: effect of leupeptin on subcellular distribution of asialo-fetuin. Int J Biochem (1981) 0.82
Interobserver agreement on classifying endoscopic diagnoses of nonerosive esophagitis. Endoscopy (2006) 0.82
Methods for handling missing data in palliative care research. Palliat Med (2006) 0.82
Separate measurements of surface shapes and refractive index inhomogeneity of an optical element using tunable-source phase shifting interferometry. Appl Opt (1990) 0.81
Characteristics and implications of attrition in health-related quality of life studies in palliative care. Palliat Med (2009) 0.81
Catabolism of (125-I)low density lipoproteins in isolated rat liver cells. Biochem Biophys Res Commun (1980) 0.81
Efficacy of twice daily versus three times daily oral ondansetron in the prevention of chemotherapy induced emesis: a randomized, single-blind, multicentre study. The Ondansetron International Emesis Study Group. Clin Oncol (R Coll Radiol) (1992) 0.80
Disclosing the cancer diagnosis: the patients' experiences. Eur J Cancer (1997) 0.80